Skip to content

CDW Corp

US · CDW #1084 by market cap Listed 1970
136.82 +1.15 +0.85%
Live - 5344 symbols - heartbeat 77s ago · 2026-10-08 06:38
Pre-market 131.03 -4.23%
After-hours 136.82 0.00%
Overnight 137.00 +0.13%
Market cap
17.10B
P/B
7.00
EPS
8.08
Reader sentiment Are you bullish or bearish on CDW?

Anonymous reader poll. Unscientific, not investment advice.

✦ Quant Ownership Signal how this is computed

Accumulating
  • The number of reporting institutions decreased by 4 in the most recent period (2026/Q3).
  • Total institutional ownership rose 0.2 percentage points.

Institutional ownership

Held by institutions
112.35% +0.25pp
Institutions
934 -4
As of
2026/Q3 vs. prior period

Ownership vs. money flow

Aligned

Institutions added shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two line up.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Holder types

Mutual Fund97.77%
Hedge Fund6.45%
Public Company3.17%
Government Pension Fund1.54%
Private Company1.42%
Family Office/Trust0.74%
Sovereign Wealth Fund0.56%
Individual/Insider0.27%
Insurance Company0.23%

Top holders as of 2026-06-30

BlackRock 12.19% · 15.24M sh
Vanguard Capital Management, LLC 7.25% · 9.06M sh
Vanguard Portfolio Management, LLC 6.56% · 8.20M sh
State Street Global Advisors 4.62% · 5.78M sh
Harris Associates L.P. 4.43% · 5.54M sh
Boston Partners Global Investors, Inc. 4.20% · 5.26M sh
Geode Capital Management, LLC 3.11% · 3.89M sh
Hotchkis and Wiley Capital Management, LLC 3.02% · 3.78M sh
Allspring Global Investments, LLC 2.50% · 3.12M sh
Eaton Vance Management 2.44% · 3.04M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 43 buys · 7 sells

NameRoleStake
Christine Leahy Chairperson & CEO 0.12%
Elizabeth Connelly Senior Vice President of Healthcare 0.03%
Frederick Kulevich Senior Vice President 0.02%
Albert Miralles Senior Vice President 0.02%
Sona Chawla Chief Growth & Innovation Officer 0.01%
David Nelms Lead Independent Director 0.01%
Lynda Clarizio Independent Director 0.01%
Joseph Swedish Independent Director 0.01%
Katherine Sanderson Chief Human Resources Officer & Executive VP Coworker Success 0.01%
Donna Zarcone Independent Director 0.01%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-09-30 David Nelms Lead Independent Director Other Acquisition +258 --
2026-09-30 Joseph Swedish Independent Director Other Acquisition +212 --
2026-09-23 Katherine Sanderson Chief Human Resources Officer & Executive VP Coworker Success Sale to Issuer -231 $153.74
2026-09-09 David Nelms Lead Independent Director Other Acquisition +147 $142.60
2026-09-09 Marc Jones Independent Director Other Acquisition +19 $142.60
2026-09-09 Christine Leahy Chairperson & CEO Other Acquisition +825 $142.60
2026-09-09 Joseph Swedish Independent Director Other Acquisition +29 $142.60
2026-09-09 James Bell Independent Director Other Acquisition +95 $142.60
2026-09-09 Lynda Clarizio Independent Director Other Acquisition +7 $142.60
2026-09-09 Kelly Grier Director Other Acquisition +7 $142.60
2026-09-09 Virginia Addicott Independent Director Other Acquisition +82 $142.60
2026-09-09 Albert Miralles Senior Vice President Other Acquisition +299 $142.60
2026-09-09 Anthony Foxx Independent Director Other Acquisition +29 $142.60
2026-09-09 Peter Locy Chief Accounting Officer Other Acquisition +29 $142.60
2026-09-09 Frederick Kulevich Senior Vice President Other Acquisition +184 $142.60
2026-09-09 Elizabeth Connelly Senior Vice President of Healthcare Other Acquisition +237 $142.60
2026-09-09 Katherine Sanderson Chief Human Resources Officer & Executive VP Coworker Success Other Acquisition +243 $142.60
2026-09-09 Mukesh Kumar Chief Services and Solutions Officer Other Acquisition +192 $142.60
2026-09-09 Hang Tan Chief Strategy & Transformation Officer Other Acquisition +212 $142.60
2026-08-16 Mukesh Kumar Chief Services and Solutions Officer Sale to Issuer -1,147 $139.42

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-10-08 06:38:26 · For reference only, not investment advice and not tailored to your situation.